Maternal Sildenafil vs Placebo in Pregnant Women With Severe Early-Onset Fetal Growth Restriction: A Randomized Clinical Trial

IMPORTANCE: Severe early onset fetal growth restriction caused by placental dysfunction leads to high rates of perinatal mortality and neonatal morbidity. The phosphodiesterase 5 inhibitor, sildenafil, inhibits cyclic guanosine monophosphate hydrolysis, thereby activating the effects of nitric oxide...

Descripción completa

Detalles Bibliográficos
Autores principales: Pels, Anouk, Derks, Jan, Elvan-Taspinar, Ayten, van Drongelen, Joris, de Boer, Marjon, Duvekot, Hans, van Laar, Judith, van Eyck, Jim, Al-Nasiry, Salwan, Sueters, Marieke, Post, Marinka, Onland, Wes, van Wassenaer-Leemhuis, Aleid, Naaktgeboren, Christiana, Jakobsen, Janus C., Gluud, Christian, Duijnhoven, Ruben G., Lely, Titia, Gordijn, Sanne, Ganzevoort, Wessel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2020
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7301225/
https://www.ncbi.nlm.nih.gov/pubmed/32585017
http://dx.doi.org/10.1001/jamanetworkopen.2020.5323

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7301225/
https://www.ncbi.nlm.nih.gov/pubmed/32585017
http://dx.doi.org/10.1001/jamanetworkopen.2020.5323

Ejemplares similares